Genomveränderungen–CRISPR/Cas9 als Methode der Wahl oder Qual?
Dimova, Elitsa Y.; Kietzmann, Thomas (2018-11-13)
Dimova, Elitsa Y.
Kietzmann, Thomas
Springer Nature
13.11.2018
Dimova, E.Y. & Kietzmann, T. Biospektrum (2018) 24: 701. https://doi.org/10.1007/s12268-018-0977-7
https://creativecommons.org/licenses/by/4.0/
© Die Autoren. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaption, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
https://creativecommons.org/licenses/by/4.0/
© Die Autoren. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaption, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
https://creativecommons.org/licenses/by/4.0/
Julkaisun pysyvä osoite on
https://urn.fi/URN:NBN:fi-fe201901303594
https://urn.fi/URN:NBN:fi-fe201901303594
Tiivistelmä
Abstract
The last years showed the rise of CRISPR/Cas9 to stardom. Several features such as programmability, specificity, and efficiency, make it to be a technique of choice for genome editing even in processes where basic aspects are not understood. However, scientific, technical and society driven challenges remain. To cope with these challenges, further research, technological improvements, translational studies as well as an open exchange between laboratories and the society are required.
Kokoelmat
- Avoin saatavuus [31941]